Gillard, J.; Picalausa, C.; Ullmer, C.; Adorini, L.; Staels, B.; Tailleux, A.; Leclercq, I.A.
Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism. Nutrients 2022, 14, 2707.
https://doi.org/10.3390/nu14132707
AMA Style
Gillard J, Picalausa C, Ullmer C, Adorini L, Staels B, Tailleux A, Leclercq IA.
Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism. Nutrients. 2022; 14(13):2707.
https://doi.org/10.3390/nu14132707
Chicago/Turabian Style
Gillard, Justine, Corinne Picalausa, Christoph Ullmer, Luciano Adorini, Bart Staels, Anne Tailleux, and Isabelle A. Leclercq.
2022. "Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism" Nutrients 14, no. 13: 2707.
https://doi.org/10.3390/nu14132707
APA Style
Gillard, J., Picalausa, C., Ullmer, C., Adorini, L., Staels, B., Tailleux, A., & Leclercq, I. A.
(2022). Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism. Nutrients, 14(13), 2707.
https://doi.org/10.3390/nu14132707